Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial

NCT00476619 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT00476619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00476619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2004
Completion date
June 30, 2008
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy